TAAR1 as an Emerging Target for the Treatment of Psychiatric Disorders

TAAR1 as an Emerging Target for the Treatment of Psychiatric Disorders - WuXi Biology

Access Resources

Thank you for your interest in our resources. Please fill out the information here to have full access to our library of useful information, including what you are looking for currently.

Name(Required)

Work Email(Required)

Company(Required)

Your Region(Required)

Your Country

U.S. State

European Country

This field is hidden when viewing the form

Your Country

This field is hidden when viewing the form

U.S. State

This field is hidden when viewing the form

Territory

← Return to Resources

Related Content

Advanced Conjugate Delivery Systems for Oligonucleotides

Oligonucleotide therapeutics represent a transformative treatment modality with demonstrated potential across metabolic disorders, CNS diseases, muscular dystrophies, and a broad...

VIEW RESOURCE

CTHRC1 as a Novel Candidate for Neurodevelopmental Disorders

Cognitive dysfunction affects over 50 million individuals worldwide, with Alzheimer’s disease (AD) representing two-thirds of cases. Due to the complexity...

VIEW RESOURCE

← View all Central Nervous System & Pain Resources

×

Access Resources

Related Content

Advanced Conjugate Delivery Systems for Oligonucleotides

CTHRC1 as a Novel Candidate for Neurodevelopmental Disorders

Contact An Expert Today!